For B cell panel, three traits were linked with increased urolithiasis risk: IgD-CD24-%lymphocyte (IVW: odds ratio/OR = 1.054; 95% confidence interval/CI: 1.019, 1.090; p = 0.002), CD24 on transitional B cells (IVW: OR = 1.068; 95% CI: 1.020, 1.117; p = 0.005), and CD25 on IgD+ CD38-naïve (IVW: OR = 1.041; 95% CI: 1.010, 1.073; p = 0.009). The gene discussed is CD38; the disease is urolithiasis.